| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $13.8M | +11.4% |
| Cost of Revenue | $6.7M | -11.2% |
| Gross Profit | $7.1M | +46.9% |
| R&D Expense | $45.6M | +94.6% |
| SG&A Expense | $48.3M | +35.6% |
| Pre-tax Income | -$102.5M | -40.5% |
| Income Tax | $617K | +86.4% |
| Net Income | -$31.6M | -3.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $238.6M | -25.9% |
| Short-term Investments | $230.7M | -26.7% |
| Accounts Receivable | $0 | -100.0% |
| Inventory | $0 | -100.0% |
| Current Assets | $268.3M | -20.1% |
| Total Assets | $438.4M | -1.3% |
| Current Liabilities | $27.8M | +30.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$156.5M | -95.3% |
| Capital Expenditures | $30.3M | +101.0% |
| Investing Cash Flow | -$31.4M | +42.8% |
| Financing Cash Flow | $102.3M | -75.5% |
| Free Cash Flow | -$186.8M | -96.3% |
| Long-term Debt |
| $4.8M |
| -4.8% |
| Total Liabilities | $78.5M | -14.6% |
| Stockholders' Equity | $359.8M | +2.2% |